Ruxolitinib (Rux) Vs Best Available Therapy (Bat) In Patients With Steroid-Refractory Acute Graft-Vs-Host Disease (Sr-Agvhd): 6-Month Follow-Up From The Randomized, Phase 3 Reach2 Study

BONE MARROW TRANSPLANTATION(2021)

引用 0|浏览1
暂无评分
关键词
ruxolitinib,ruxolitinib,steroid-refractory,graft-vs-host,sr-agvhd
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要